List of Clinical Trials
Trial 1
Safety, Feasibility and Metabolic Effects of the Fasting Mimicking Diet (FMD) in Cancer Patients
Trial 2
Impact of Dietary Intervention on Tumor Immunity – The DlgesT Trial
Trial 3
Os-10-3 — A Randomized, Phase II Clinical Trial of a Controlled Diet Prior to Selected Chemotherapy Treatment in Breast and Prostate Cancer to Evaluate the Impact on Toxicity and Efficacy
Trial 4
Phase II Study of a Diet that Simulates Fasting in Patients Undergoing Cancer Treatment
Trial 5
BRCA Main Home Study — Use of FMD in a Group of People Who Carry Mutations in Susceptibility Genes for Breast Cancer
Trial 6
Dietary Restriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer (DIRECT)
Trial 7
Fasting and Nutritional Therapy in Patients with Advanced Metastatic Prostate Cancer
Trial 8
Fasting and Cancer Treatment in Humans — A Case Series Report
Trial 9
Effects of Short-Term Fasting on Tolerance to Adjuvant Chemotherapy in Breast Cancer Patients
Trial 10
Short-Term Fasting Prior To Platinum-Based Chemotherapy — Feasibility and Impact on Toxicity
Trial 11
Short-Term Fasting During Chemotherapy in Patients with Gynecological Cancer — A Randomized Controlled Cross-over Trial (FIT)
Trial 12
Fasting Mimicking Diet in Patients Receiving Chemo-Immunotherapy for Treatment of Metastatic Non-Small Cell Lung Cancer
Trial 13
Fasting Mimicking Diet on Central and Peripheral Components of Fatigue, Muscular Resistance
Trial 14
Primitive Glomerulonephritis and Chronic Kidney Disease in Conservative Therapy with eGFR ≤ 60 ml/min (3 stage kdoqi)
Trial 15
The Randomized Pilot Study to Evaluate the Efficacy and Safety of ProLon, a Fasting Mimicking Diet, as Add-On Therapy in Hashimoto’s Thyroiditis.
Trial 16
Randomized Phase I/II Study of a Hypoproteic Diet in Patients with Cognitive Impairment
Trial 17
Multiple Sclerosis
Trial 18
Studio Randomizzato di Fase I/II di una Dieta Ipoproteica in Pazienti con Sindrome Metabolica
Trial 19
Safety and Feasibility of Fasting in Combination with Platinum-Based Chemotherapy
Trial 20
To Evaluate the Efficacy and Safety of ProLon, a Fasting Mimicking Diet on Metabolic Syndrome
Trial 21
Evaluate the Efficacy and Safety of a Fasting Mimicking Diet, as Add-On Therapy, on Clinical Response in Patients with Active, Mild to Moderate Ulcerative Colitis
Trial 22
Evaluate the Efficacy and Safety of a Fasting Mimicking Diet, as Add-On Therapy, on Clinical Response in Patients with Active Crohn’s Disease
Trial 23
Five Meals a Day vs. Two Meals a Day — To Evaluate the Consumption of Two Meals Plus One Snack per Day Compared to Five Meals per Day on Initial Weight Loss and Weight Maintenance over the Period of 12 Months in Overweight and Obese Individuals (with BMI > 27)
Trial 24
Fasting Mimicking Diet Study Protocol
Trial 25
PCI.GC.002 — A Prospective Pilot Cohort Study of Patients with a Known Diagnosis of Cancer, to Document its Metabolic Effects, including Cancer Fatigue, and Metabolic Syndrome, as well as Lifestyle Changes in the Clinic
Trial 26
Fasting Mimicking Diet, Modified Ketogenic Diet, and Time Restricted Feedings as Adjuvant Therapy for Newly Diagnosed Glioblastoma Multiforme Patients
Trial 27
The Effect of Dietary Interventions on Endothelial Glycocalyx Dimensions and Barrier Function in South Asian Patients with Diabetic Nephropathy (Glycotreat Study)
Trial 28
Chronic Fasting and the Late Complications of Diabetes: A Prospective Explanatory Randomized Controlled Study in Patients with Diabetes Mellitus Type 2
Trial 29
Pilot Study on the Effects of Fasting Mimicking Diet (FMD) in Women with Polycystic Ovary Syndrome (PCOS)
Trial 30
Fasting Mimicking Diet — A Randomized Trial on Feasibility, Safety and Effects of Multicycle Dietary Intervention on Side Effects of Aromatase Inhibitors Treatment in Post-Menopausal Patients with Breast Cancer
Trial 31
Phase I, Pilot, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ProMet, a Fasting Mimicking Diet, on Inflammatory Cardiomyopathy
Trial 32
Cephalalgy
Trial 33
Melanoma Immunotherapy and FMD
Trial 34
Depression
Trial 35
Liver Transplant
Trial 36
Obesity-Associated Olfact Deficit and FMD
Trial 37
Bariatric Surgery
Trial 38
Pedriatic Type 1 Diabetes
Trial 39
Colorectal
Trial 40
Clinical Feasibility and Efficacy of Intermittent Use of a Fasting Mimicking Diet in the Treatment of Type 2 Diabetes — Fasting in Diabetes Treatment (FIT) Study
Trial 41
FMD and Insulin Resistant Adolescents (Females)
Trial 42
FMD AND IBD
Via XX Settembre, 12/2E - 16121
GENOVA (GE), ITALIA P.I 02140480993
GENOVA (GE), ITALIA P.I 02140480993
(+39) 3271180483
FOLLOW US
HEALTH CARE PROVIDERS
Health Care Providers interested in authorizing ProLon® for their patients can Register on the their national ProLon® website.
DISCLAIMER
The statements on this site have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
PEOPLE AFFECTED BY DIABETES
WARNING RELATED TO OUR RECENT STUDIES ON DIABETES: DO NOT TRY TO APPLY ANY TYPE OF FASTING MIMICKING DIET TO TREAT EITHER TYPE 1 OR TYPE 2 DIABETES ALONE OR EVEN WITH THE HELP OF A DOCTOR. THE COMBINATION OF THE FMD AND INSULIN BUT ALSO OTHER DRUGS COULD CAUSE SEVERE PROBLEMS. ALTHOUGH THE USE OF THE FMD TO TREAT EITHER TYPE 1 OR 2 DIABETES IS PROMISING, IT MUST BE FIRST TESTED AND PROVEN EFFECTIVE IN FDA CLINICAL TRIALS WHICH WILL PROBABLY REQUIRE HOSPITALIZATION DURING THE TREATMENT.